Facing global food shortages, will ESG investing embrace sustainable gene-edited crops — or continue to reject biotech?

Credit: Convene ESG
Credit: Convene ESG

The need to feed an expanding population while cutting agriculture’s high greenhouse gas emissions means farming must become more efficient. The increased use of genetic technology in seed manufacture is one solution. Yet GMOs remain a bugbear for many [Environmental, Social and Corporate Governance, or] ESG funds, which are wary of the unintended consequences of intervening in the food chain (the so-called precautionary principle).

The difficulty with this cautious position is that it becomes harder to maintain if it exacerbates the risk of a food crisis. And so some investors are now betting that ESG sentiment will shift.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Emissions from food production are becoming part of the corporate and investor conversation. French dairy giant Danone SA said last month it was targeting a 30% reduction in methane emissions from its fresh-milk supply chain by 2030. Others will come under pressure to make similar commitments. Index provider MSCI Inc. modified its ESG exclusion criteria last year, with the result that companies involved in GMOs may now be less likely to attract a red flag. Analysts also point to so-called gene editing being potentially more acceptable to the public and regulators than genetic modification, as GE involves altering a plant’s DNA without introducing a foreign gene, as in GMOs.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT Image Jul 29, 2026, 05_50_04 PM
Fear, science, and the law: If talc powder is unlikely to cause cancer and J&J was winning in court, why did it pay more than $5.5 billion to settle?
ChatGPT Image Jul 29, 2026, 10_14_27 PM
After muzzling RFK, Jr. over autism-vaccine conspiracy theories, Trump defies aides to push scares again
Screenshot 2026-07-29 at 1.03
Two food fads that have some merit: Chia seeds in almost everything and protein added to water
ChatGPT Image Jul 29, 2026, 06_26_01 PM 2
Facts & Fallacies podcast: Organic food myths make a comeback on Instagram, with Dr. Kevin Folta
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT Image Jul 29, 2026, 10_31_48 PM
Bowing to Congressional pressure, Kennedy reverses himself and releases $600 million that helps developing countries buy and distribute vaccines
Screenshot-2026-07-09-at-1.09.25-PM
Anti-vaccine myths rattle health care
Screenshot 2026-07-28 at 3.22
Hidden hunger: Climate change is speeding up the decline of important nutrients in our food
Screenshot 2026-07-28 at 3.43
Fat cat? GLP-1 weight loss drugs for animals are on the horizon
Screenshot 2026-07-22 at 1.38
Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?
organic scaled
Facts & Fallacies podcast: Organic food cuts pesticide exposure? A response to Dr. Rhonda Patrick
ChatGPT-Image-Jul-10-2026-09_42_12-AM-1
Peptides, patient autonomy, and the limits of medical freedom
Screenshot 2026-07-28 at 3.03
What is cyberchondria?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.